logo

For the Inventor, By the Inventor

Welwyn Garden City, United Kingdom

David A Owen

This inventor holds 6 USPTO granted patents. Top assignee: Smith Kline & French Laboratories Limited. Active years: 1981-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David A Owen. Retrieved from https://idiyas.com/inventor/david-a-owen-pcijqrgs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 1.8

ph-index = 3

Forward Citations = 41(Granted Patents)


Company Filing History:

goldMedal6 out of 362 
 
Smith Kline & French Laboratories Limited
 patents

Years Active: 1981-1990

Loading Chart...
6 patents (USPTO):Explore Patents
1. 4912126 - Producing anxiolytic activity and treating depression with 3(H)-indolones (1990-03-27),
2. 4824860 - Treatment of Parkinsons disease (1989-04-25),
3. 4639519 - 2-substituted alkylaminopyrimidones useful as H.sub.2 -antagonists and (1987-01-27),
4. 4558128 - 2-Substituted alkylaminopyrimidones (1985-12-10),
5. 4439435 - Isoureas and isothioureas (1984-03-27),
6. 4305945 - Isoureas and isothioureas (1981-12-15),

Title: David A Owen: Innovator in Anxiolytic and Parkinson's Disease Treatments

Introduction

David A Owen is a notable inventor based in Welwyn Garden City, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of anxiety and Parkinson's disease. With a total of 6 patents to his name, Owen's work has the potential to impact many lives.

Latest Patents

Owen's latest patents focus on producing anxiolytic activity and treating depression with 3(H)-indolones. One of his key inventions involves the use of certain indolone derivatives, specifically 4-(2-di-n-propyl-aminoethyl)-2-(3H)-indolone, in methods for treating Parkinson's disease. This innovative approach highlights the therapeutic potential of these compounds in addressing neurological disorders.

Career Highlights

David A Owen is associated with Smith Kline & French Laboratories Limited, where he has been instrumental in advancing research and development in his field. His work has garnered attention for its relevance and applicability in modern medicine.

Collaborations

Owen has collaborated with esteemed colleagues such as Charon R Ganellin and Robert John Ife. These partnerships have contributed to the depth and breadth of his research, enhancing the impact of his inventions.

Conclusion

David A Owen's contributions to the field of pharmaceuticals, particularly in the treatment of anxiety and Parkinson's disease, underscore his role as an influential inventor. His innovative work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…